What is VOGX's current stock price?

VOGX (Vogenx Inc.) is currently trading at $31.73 with a market cap of $441.2M.

What sector is Vogenx Inc. in?

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

VOGX Vogenx Inc.

NASDAQHealthcare

$31.73-1.31%ClosedMarket Cap: $441.2M

As of 2026-09-04

Why VOGX matters now

Vogenx Inc. (VOGX) is a US stock in Healthcare. The latest InvestLog snapshot shows $31.73 with -1.31% on the session and $441.2M in market capitalization.

The latest indexable market news headline is "Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering" from PRNewsWire.

Latest News

Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public OfferingPRNewsWire · 2026-08-17

Vogenx Announces Closing of Initial Public OfferingAccesswire · 2026-08-13

Vogenx Announces Pricing of Initial Public OfferingAccesswire · 2026-08-11

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.